1. Cannabis and cannabis-derived compounds: quality considerations for clinical research : guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, January 2023 Subject(s): CannabisDrug DevelopmentGovernment RegulationMedical MarijuanaUnited StatesUnited States. Food and Drug Administration
